🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2025 | 84,42 | 84,78 | 82,09 | 83,01 | -1,67% | 3,19% | 26.779.000 |
| 13/02/2025 | 85,59 | 85,70 | 84,31 | 84,42 | -1,46% | 1,62% | 20.415.100 |
| 12/02/2025 | 86,07 | 86,67 | 85,61 | 85,67 | -1,01% | 1,23% | 14.785.300 |
| 11/02/2025 | 86,06 | 86,99 | 85,73 | 86,54 | +0,16% | 1,46% | 20.922.300 |
| 10/02/2025 | 87,20 | 87,98 | 86,27 | 86,40 | -1,01% | 1,96% | 21.212.100 |
| 07/02/2025 | 87,52 | 88,60 | 87,12 | 87,28 | -0,87% | 1,69% | 15.815.000 |
| 06/02/2025 | 89,41 | 89,57 | 87,84 | 88,05 | -1,81% | 1,93% | 19.509.700 |
| 05/02/2025 | 90,39 | 90,74 | 88,00 | 89,67 | -1,18% | 3,03% | 21.670.600 |
| 04/02/2025 | 89,00 | 91,23 | 87,33 | 90,74 | -9,07% | 4,38% | 50.837.600 |
| 03/02/2025 | 98,13 | 100,15 | 98,00 | 99,79 | +0,98% | 2,19% | 13.363.900 |
| 31/01/2025 | 99,10 | 100,06 | 98,58 | 98,82 | -0,13% | 1,49% | 11.420.200 |
| 30/01/2025 | 99,41 | 99,41 | 98,23 | 98,95 | +0,68% | 1,19% | 10.164.700 |
| 29/01/2025 | 97,42 | 99,15 | 97,39 | 98,28 | +0,85% | 1,81% | 10.225.500 |
| 28/01/2025 | 97,35 | 98,88 | 96,59 | 97,45 | -0,50% | 2,35% | 12.840.900 |
| 27/01/2025 | 96,63 | 98,62 | 95,98 | 97,94 | +2,50% | 2,73% | 15.093.400 |
| 24/01/2025 | 96,79 | 97,10 | 95,41 | 95,55 | -1,12% | 1,75% | 12.244.800 |
| 23/01/2025 | 96,11 | 97,16 | 95,22 | 96,63 | +0,99% | 2,02% | 11.522.800 |
| 22/01/2025 | 95,96 | 97,00 | 95,15 | 95,68 | -0,58% | 1,93% | 13.070.900 |
| 21/01/2025 | 98,08 | 98,27 | 95,76 | 96,24 | -1,72% | 2,56% | 17.756.100 |
| 17/01/2025 | 100,47 | 100,47 | 97,92 | 97,92 | -2,76% | 2,54% | 16.182.000 |
| 16/01/2025 | 100,44 | 100,90 | 99,95 | 100,70 | +0,61% | 0,95% | 7.749.600 |
| 15/01/2025 | 100,10 | 100,82 | 99,61 | 100,09 | +0,44% | 1,21% | 9.170.300 |
| 14/01/2025 | 101,26 | 101,49 | 99,01 | 99,65 | -1,32% | 2,45% | 10.927.400 |
| 13/01/2025 | 99,46 | 101,16 | 98,99 | 100,98 | +1,74% | 2,18% | 8.168.100 |
| 10/01/2025 | 99,21 | 100,41 | 98,81 | 99,25 | -0,60% | 1,61% | 11.328.500 |
| 08/01/2025 | 100,70 | 100,77 | 98,05 | 99,85 | -1,16% | 2,70% | 8.654.700 |
| 07/01/2025 | 100,13 | 102,97 | 100,05 | 101,02 | +1,30% | 2,92% | 10.890.900 |
| 06/01/2025 | 98,77 | 100,33 | 98,42 | 99,72 | +0,59% | 1,93% | 10.111.100 |
| 03/01/2025 | 99,34 | 99,75 | 98,69 | 99,14 | -0,03% | 1,07% | 6.070.300 |
| 02/01/2025 | 100,28 | 100,35 | 98,83 | 99,17 | -0,31% | 1,52% | 6.153.300 |